Safety and Efficacy of the Combination of Selinexor, Lenalidomide and Dexamethasone (SRd) in Patients with Relapsed/Refractory Multiple Myeloma (RRMM)

Clinical Lymphoma Myeloma and Leukemia(2019)

引用 7|浏览44
暂无评分
关键词
Lenalidomide,novel agents,relapsed/refractory multiple myeloma
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要